Pay in 4 interest-free payments of $5.00 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
February 24, 2026
Potential benefits: Lower glucose exposure, less insulin required, sometimes improved variability
You have obesity with diabetes, PCOS, hypertension, or insulin resistance and want a provider to review whether oral therapy makes sense
Zepbound makes sense if you: Want to start treatment now under a licensed prescriber Value a drug with completed Phase 3 data and FDA approval Have insurance coverage or can use the self-pay vial program Prefer a known, regulated safety profile Retatrutide may interest you if you: Are tracking the most aggressive weight-loss results in development Did not reach your goal on tirzepatide and want to know what comes next Are willing to wait for FDA approval rather than buy unregulated material Want to discuss clinical trial enrollment with your doctor For people already on Zepbound who are curious about a future switch, the practical considerations are laid out in switching from tirzepatide to retatrutide
